Onconetix, Inc. Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
Onconetix, Inc. (ONCO) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of $9.83 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2026-03-13
- Onconetix, Inc. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2025 was $9.83K.
- Onconetix, Inc. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2024 was -$253.36K, a 556.62% decline from fiscal 2023.
- Onconetix, Inc. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2023 was $55.49K, a 71.50% decline from fiscal 2022.
- Onconetix, Inc. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2022 was $194.71K, a 100.00% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $9.83K 10-K · filed 2026-03-13 | |
| 2024-12-31 | -$253.36K 10-K · filed 2026-03-13 | -$244.40K 10-K · filed 2025-06-02 |
| 2023-12-31 | $55.49K 10-K · filed 2025-06-02 | |
| 2022-12-31 | $194.71K 10-K · filed 2024-04-11 | $194.71B 10-K · filed 2023-03-09 |
| 2021-12-31 | $9.50B 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |